In patients with cardiovascular risk factors, such as hypertension, obesity and diabetes, extensive data demonstrate that MR activation contributes to endothelial dysfunction, through impairment of vasodilation induced by the endothelium (22, 85, 88–91). The gene discussed is NR3C2; the disease is obesity disorder.